CBIO vs PULM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 14, 2026

CBIO

35.9
AI Score
VS
PULM Wins

PULM

42.9
AI Score

Investment Advisor Scores

CBIO

36score
Recommendation
SELL

PULM

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CBIO PULM Winner
Revenue 1.04M 7.80M PULM
Net Income -48.12M -7.57M PULM
Net Margin -4631.4% -97.1% PULM
Operating Income -51.09M -7.81M PULM
ROE -29.5% -69.3% CBIO
ROA -26.3% -65.8% CBIO
Total Assets 182.76M 11.51M CBIO
Cash 171.59M 10.78M CBIO
Current Ratio 9.66 19.40 PULM
Free Cash Flow -28.56M -9.85M PULM

Relative Price Performance (Last 90 Days)

CBIO 1M: +0.7% · 3M: -15.2% PULM 1M: -11.5% · 3M: +17.7%

Current Technical Phase

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.0 · Price: $17.15

PULM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 39

RSI (14): 38.9 · Price: $1.50

Fundamentals Snapshot

Metric CBIO PULM
Market Cap
Forward P/E -6.5 0.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% -1.0%
Gross Margin 1.0% -12.7%
Operating Margin -14.3% 0.0%
EPS -0.13 -1.10
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PULM is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.